Trials / Conditions / Esophageal Adenocarcinoma (EAC)
Esophageal Adenocarcinoma (EAC)
3 registered clinical trials studyying Esophageal Adenocarcinoma (EAC) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Combination of Chemotherapy and Adaptive MR-Guided Radiotherapy to Improve Outcomes in Patients With Esophagea NCT07359443 | UMC Utrecht | Phase 1 |
| Active Not Recruiting | Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, NCT06504615 | Bristol-Myers Squibb | — |
| Active Not Recruiting | Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Ch NCT04210115 | Merck Sharp & Dohme LLC | Phase 3 |